Suppr超能文献

R-α-甲基组胺对豚鼠基础血管阻力的组胺H3受体介导性降低作用。

Production by R-alpha-methylhistamine of a histamine H3 receptor-mediated decrease in basal vascular resistance in guinea-pigs.

作者信息

McLeod R L, Gertner S B, Hey J A

机构信息

Department of Pharmacology and Toxicology, New Jersey Medical School-UMDNJ, Newark.

出版信息

Br J Pharmacol. 1993 Oct;110(2):553-8. doi: 10.1111/j.1476-5381.1993.tb13846.x.

Abstract
  1. The effect of the selective histamine H3 receptor agonist, R-alpha-methylhistamine given intravenously (10-100 micrograms kg-1) was examined on baseline total peripheral resistance (TPR), and cardiovascular haemodynamics in bilaterally vagotomized, anaesthetized guinea-pigs. 2. R-alpha-methylhistamine produced a dose-dependent hypotension and fall in TPR at 30 and 100 micrograms kg-1. A decrease in heart rate (HR) was observed at a dose of 100 micrograms kg-1. R-alpha-methylhistamine (10-100 micrograms kg-1) also produced a dose-dependent fall in rate pressure product (RPP). There was no effect on cardiac output (CO) or stroke volume (SV) at these doses. 3. Histamine H1 and H2 blockade in animals pretreated with a combination of chlorpheniramine (0.3 mg kg-1) and cimetidine (3.0 mg kg-1) did not alter the haemodynamic actions of R-alpha-methyl-histamine (100 micrograms kg-1, i.v.). Pretreatment with the selective H3 antagonist, thioperamide (1 mg kg-1), completely blocked the action of R-alpha-methylhistamine on haemodynamic parameters. 4. To study the mechanism of action of R-alpha-methylhistamine, the vasodilator hydralazine (1 mg kg-1, i.v.) was used. Hydralazine lowered BP, TRP and RPP in guinea-pigs pretreated with ipratropium (50 micrograms kg-1, i.v.). Hydralazine had no effect on HR, SV or CO. 5. R-alpha-methylhistamine (100 micrograms kg-1) did not affect the vasopressor action and increases in TPR produced by adrenaline (1 and 3 micrograms kg-1). On the other hand, the vasodilator hydralazine (1 mg kg-1, i.v.) inhibited the effects of adrenaline (3 micrograms kg-1) on TPR and RPP. The effect of both doses of adrenaline on BP were attenuated by hydralazine. Therefore, the inhibitory effects of R-alpha-methylhistamine are not mediated through a direct action on vascular smooth muscle.6. In adrenalectomized guinea-pigs, R-alpha-methylhistamine (100 microg kg-1) produced a drop in BP and HR.There was no difference between the effects of R-alpha-methylhistamine on blood pressure and heart rate in adrenalectomized and non-adrenalectomized guinea-pigs.7. These results show that activation of peripheral H3 receptors lowers basal BP, HR and TPR, most likely by a peripheral prejunctional mechanism. The fall in BP and TPR is probably due to a decrease in noradrenaline release from sympathetic effector nerves innervating the resistance blood vessels.
摘要
  1. 研究了静脉注射选择性组胺H3受体激动剂R-α-甲基组胺(10 - 100微克/千克)对双侧迷走神经切断的麻醉豚鼠的基础总外周阻力(TPR)和心血管血流动力学的影响。2. R-α-甲基组胺在30和100微克/千克时产生剂量依赖性低血压和TPR下降。在100微克/千克剂量时观察到心率(HR)降低。R-α-甲基组胺(10 - 100微克/千克)也产生剂量依赖性的速率压力乘积(RPP)下降。在这些剂量下对心输出量(CO)或每搏量(SV)没有影响。3. 用氯苯那敏(0.3毫克/千克)和西咪替丁(3.0毫克/千克)联合预处理的动物中,组胺H1和H2阻断并未改变R-α-甲基组胺(100微克/千克,静脉注射)的血流动力学作用。用选择性H3拮抗剂硫代哌酰胺(1毫克/千克)预处理可完全阻断R-α-甲基组胺对血流动力学参数的作用。4. 为研究R-α-甲基组胺的作用机制,使用了血管扩张剂肼屈嗪(1毫克/千克,静脉注射)。肼屈嗪降低了用异丙托溴铵(50微克/千克,静脉注射)预处理的豚鼠的血压、TRP和RPP。肼屈嗪对HR、SV或CO没有影响。5. R-α-甲基组胺(100微克/千克)不影响肾上腺素(1和3微克/千克)产生的升压作用和TPR增加。另一方面,血管扩张剂肼屈嗪(1毫克/千克,静脉注射)抑制了肾上腺素(3微克/千克)对TPR和RPP的作用。两种剂量的肾上腺素对血压的作用均被肼屈嗪减弱。因此,R-α-甲基组胺的抑制作用不是通过对血管平滑肌的直接作用介导的。6. 在肾上腺切除的豚鼠中,R-α-甲基组胺(100微克/千克)导致血压和心率下降。肾上腺切除和未肾上腺切除的豚鼠中,R-α-甲基组胺对血压和心率的影响没有差异。7. 这些结果表明,外周H3受体的激活降低基础血压、心率和TPR,最可能是通过外周节前机制。血压和TPR的下降可能是由于支配阻力血管的交感效应神经去甲肾上腺素释放减少所致。

相似文献

本文引用的文献

4
Coronary circulation during heavy exercise in control subjects and patients with coronary heart disease.
Acta Med Scand. 1971 Dec;190(6):465-80. doi: 10.1111/j.0954-6820.1971.tb07462.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验